APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Blood-derived Products

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Blood-derived Products Industry Growth and Trends Forecast to 2032

Report ID 173971600123 December 2025105 pages

Choose your research edition.

Industry ResearchBlood-derived Products Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood-derived Products Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Blood-derived Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood-derived Products Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood-derived Products Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Blood-derived Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Blood-derived Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Blood-derived Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood-derived Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood-derived Products include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Shanghai RAAS, Hualan Bio, Boya Bio and CBPO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Blood-derived Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Blood-derived Products market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blood-derived Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blood-derived Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Blood-derived Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Blood-derived Products Market by Company

Yuanda Shuyang

Takeda

Weiguang Bio

Tiantan Bio

Shuanglin Bio

Shanghai RAAS

Hualan Bio

Boya Bio

CBPO

Octapharma

LFB Group

Kedrion

Grifols

CSL

Blood-derived Products Segment by Type

Coagulation Factors

Immunoglobulins

Albumin

Others

Blood-derived Products Segment by Application

Therapeutics

Excipient

Other

Blood-derived Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood-derived Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood-derived Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood-derived Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood-derived Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Blood-derived Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Coagulation Factors Table 2. Major Company of Immunoglobulins Table 3. Major Company of Albumin Table 4. Major Company of Others Table 5. Global Blood-derived Products Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Blood-derived Products Sales by Type (2021-2026) & (t) Table 7. Global Blood-derived Products Sales Market Share in Volume by Type (2021-2026) Table 8. Global Blood-derived Products Sales by Type (2021-2026) & (US$ Million) Table 9. Global Blood-derived Products Sales Market Share in Value by Type (2021-2026) Table 10. Global Blood-derived Products Price by Type (2021-2026) & (USD/kg) Table 11. Global Blood-derived Products Sales by Type (2027-2032) & (t) Table 12. Global Blood-derived Products Sales Market Share in Volume by Type (2027-2032) Table 13. Global Blood-derived Products Sales by Type (2027-2032) & (US$ Million) Table 14. Global Blood-derived Products Sales Market Share in Value by Type (2027-2032) Table 15. Global Blood-derived Products Price by Type (2027-2032) & (USD/kg) Table 16. North America Blood-derived Products Sales by Type (2021-2026) & (t) Table 17. North America Blood-derived Products Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Blood-derived Products Sales by Type (2021-2026) & (t) Table 19. Europe Blood-derived Products Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Blood-derived Products Sales by Type (2021-2026) & (t) Table 21. Asia-Pacific Blood-derived Products Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Blood-derived Products Sales by Type (2021-2026) & (t) Table 23. Latin America Blood-derived Products Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Blood-derived Products Sales by Type (2021-2026) & (t) Table 25. Middle East and Africa Blood-derived Products Sales by Type (2021-2026) & (US$ Million) Table 26. Blood-derived Products Industry Trends Table 27. Blood-derived Products Industry Drivers Table 28. Blood-derived Products Industry Opportunities and Challenges Table 29. Blood-derived Products Industry Restraints Table 30. Global Blood-derived Products Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Blood-derived Products Revenue Market Share by Company (2021-2026) Table 32. Global Blood-derived Products Sales by Company (2021-2026) & (t) Table 33. Global Blood-derived Products Sales Share by Company (2021-2026) Table 34. Global Blood-derived Products Market Price by Company (2021-2026) & (USD/kg) Table 35. Global Blood-derived Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Blood-derived Products Major Company Production Sites and Headquarters Table 37. Global Blood-derived Products Company, Product Type & Application Table 38. Global Blood-derived Products Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Blood-derived Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Blood-derived Products Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Blood-derived Products Sales by Region (2021-2026) & (t) Table 43. Global Blood-derived Products Sales Market Share in Volume by Region (2021-2026) Table 44. Global Blood-derived Products Sales by Region (2021-2026) & (US$ Million) Table 45. Global Blood-derived Products Sales Market Share in Value by Region (2021-2026) Table 46. Global Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 47. Global Blood-derived Products Sales by Region (2027-2032) & (t) Table 48. Global Blood-derived Products Sales Market Share in Volume by Region (2027-2032) Table 49. Global Blood-derived Products Sales by Region (2027-2032) & (US$ Million) Table 50. Global Blood-derived Products Sales Market Share in Value by Region (2027-2032) Table 51. Global Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 52. Global Blood-derived Products Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Blood-derived Products Sales by Application (2021-2026) & (t) Table 54. Global Blood-derived Products Sales Market Share in Volume by Application (2021-2026) Table 55. Global Blood-derived Products Sales by Application (2021-2026) & (US$ Million) Table 56. Global Blood-derived Products Sales Market Share in Value by Application (2021-2026) Table 57. Global Blood-derived Products Price by Application (2021-2026) & (USD/kg) Table 58. Global Blood-derived Products Sales by Application (2027-2032) & (t) Table 59. Global Blood-derived Products Sales Market Share in Volume by Application (2027-2032) Table 60. Global Blood-derived Products Sales by Application (2027-2032) & (US$ Million) Table 61. Global Blood-derived Products Sales Market Share in Value by Application (2027-2032) Table 62. Global Blood-derived Products Price by Application (2027-2032) & (USD/kg) Table 63. North America Blood-derived Products Sales by Application (2021-2026) & (t) Table 64. North America Blood-derived Products Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Blood-derived Products Sales by Application (2021-2026) & (t) Table 66. Europe Blood-derived Products Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Blood-derived Products Sales by Application (2021-2026) & (t) Table 68. Asia-Pacific Blood-derived Products Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Blood-derived Products Sales by Application (2021-2026) & (t) Table 70. Latin America Blood-derived Products Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Blood-derived Products Sales by Application (2021-2026) & (t) Table 72. Middle East and Africa Blood-derived Products Sales by Application (2021-2026) & (US$ Million) Table 73. Yuanda Shuyang Company Information Table 74. Yuanda Shuyang Business Overview Table 75. Yuanda Shuyang Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 76. Yuanda Shuyang Blood-derived Products Product Portfolio Table 77. Yuanda Shuyang Recent Development Table 78. Takeda Company Information Table 79. Takeda Business Overview Table 80. Takeda Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 81. Takeda Blood-derived Products Product Portfolio Table 82. Takeda Recent Development Table 83. Weiguang Bio Company Information Table 84. Weiguang Bio Business Overview Table 85. Weiguang Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 86. Weiguang Bio Blood-derived Products Product Portfolio Table 87. Weiguang Bio Recent Development Table 88. Tiantan Bio Company Information Table 89. Tiantan Bio Business Overview Table 90. Tiantan Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 91. Tiantan Bio Blood-derived Products Product Portfolio Table 92. Tiantan Bio Recent Development Table 93. Shuanglin Bio Company Information Table 94. Shuanglin Bio Business Overview Table 95. Shuanglin Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 96. Shuanglin Bio Blood-derived Products Product Portfolio Table 97. Shuanglin Bio Recent Development Table 98. Shanghai RAAS Company Information Table 99. Shanghai RAAS Business Overview Table 100. Shanghai RAAS Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 101. Shanghai RAAS Blood-derived Products Product Portfolio Table 102. Shanghai RAAS Recent Development Table 103. Hualan Bio Company Information Table 104. Hualan Bio Business Overview Table 105. Hualan Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 106. Hualan Bio Blood-derived Products Product Portfolio Table 107. Hualan Bio Recent Development Table 108. Boya Bio Company Information Table 109. Boya Bio Business Overview Table 110. Boya Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 111. Boya Bio Blood-derived Products Product Portfolio Table 112. Boya Bio Recent Development Table 113. CBPO Company Information Table 114. CBPO Business Overview Table 115. CBPO Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 116. CBPO Blood-derived Products Product Portfolio Table 117. CBPO Recent Development Table 118. Octapharma Company Information Table 119. Octapharma Business Overview Table 120. Octapharma Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 121. Octapharma Blood-derived Products Product Portfolio Table 122. Octapharma Recent Development Table 123. LFB Group Company Information Table 124. LFB Group Business Overview Table 125. LFB Group Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 126. LFB Group Blood-derived Products Product Portfolio Table 127. LFB Group Recent Development Table 128. Kedrion Company Information Table 129. Kedrion Business Overview Table 130. Kedrion Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 131. Kedrion Blood-derived Products Product Portfolio Table 132. Kedrion Recent Development Table 133. Grifols Company Information Table 134. Grifols Business Overview Table 135. Grifols Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 136. Grifols Blood-derived Products Product Portfolio Table 137. Grifols Recent Development Table 138. CSL Company Information Table 139. CSL Business Overview Table 140. CSL Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 141. CSL Blood-derived Products Product Portfolio Table 142. CSL Recent Development Table 143. North America Blood-derived Products Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 144. North America Blood-derived Products Sales by Country (2021-2026) & (t) Table 145. North America Blood-derived Products Sales Market Share by Country (2021-2026) Table 146. North America Blood-derived Products Sales Forecast by Country (2027-2032) & (t) Table 147. North America Blood-derived Products Sales Market Share Forecast by Country (2027-2032) Table 148. North America Blood-derived Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Blood-derived Products Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Blood-derived Products Market Share by Country (2021-2026) Table 151. North America Blood-derived Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Blood-derived Products Market Share Forecast by Country (2027-2032) Table 153. Europe Blood-derived Products Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 154. Europe Blood-derived Products Sales by Country (2021-2026) & (t) Table 155. Europe Blood-derived Products Sales Market Share by Country (2021-2026) Table 156. Europe Blood-derived Products Sales Forecast by Country (2027-2032) & (t) Table 157. Europe Blood-derived Products Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Blood-derived Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Blood-derived Products Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Blood-derived Products Market Share by Country (2021-2026) Table 161. Europe Blood-derived Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Blood-derived Products Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Blood-derived Products Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Blood-derived Products Sales by Country (2021-2026) & (t) Table 165. Asia-Pacific Blood-derived Products Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Blood-derived Products Sales Forecast by Country (2027-2032) & (t) Table 167. Asia-Pacific Blood-derived Products Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Blood-derived Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Blood-derived Products Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Blood-derived Products Market Share by Country (2021-2026) Table 171. Asia-Pacific Blood-derived Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Blood-derived Products Market Share Forecast by Country (2027-2032) Table 173. Latin America Blood-derived Products Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 174. Latin America Blood-derived Products Sales by Country (2021-2026) & (t) Table 175. Latin America Blood-derived Products Sales Market Share by Country (2021-2026) Table 176. Latin America Blood-derived Products Sales Forecast by Country (2027-2032) & (t) Table 177. Latin America Blood-derived Products Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Blood-derived Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Blood-derived Products Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Blood-derived Products Market Share by Country (2021-2026) Table 181. Latin America Blood-derived Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Blood-derived Products Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Blood-derived Products Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Blood-derived Products Sales by Country (2021-2026) & (t) Table 185. Middle East and Africa Blood-derived Products Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Blood-derived Products Sales Forecast by Country (2027-2032) & (t) Table 187. Middle East and Africa Blood-derived Products Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Blood-derived Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Blood-derived Products Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Blood-derived Products Market Share by Country (2021-2026) Table 191. Middle East and Africa Blood-derived Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Blood-derived Products Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Blood-derived Products Distributors List Table 196. Blood-derived Products Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Blood-derived Products Image Figure 2. Global Blood-derived Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood-derived Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood-derived Products Sales (2021-2032) & (t) Figure 5. Coagulation Factors Image Figure 6. Global Coagulation Factors Sales YoY Growth (2021-2032) & (t) Figure 7. Immunoglobulins Image Figure 8. Global Immunoglobulins Sales YoY Growth (2021-2032) & (t) Figure 9. Albumin Image Figure 10. Global Albumin Sales YoY Growth (2021-2032) & (t) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (t) Figure 13. Global Blood-derived Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Blood-derived Products Market Share by Type 2025 VS 2032 Figure 15. North America Blood-derived Products Sales Market Share in Volume by Type in 2025 Figure 16. North America Blood-derived Products Sales Market Share in Value by Type in 2025 Figure 17. Europe Blood-derived Products Sales Market Share in Volume by Type in 2025 Figure 18. Europe Blood-derived Products Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Blood-derived Products Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Blood-derived Products Sales Market Share in Value by Type in 2025 Figure 21. Latin America Blood-derived Products Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Blood-derived Products Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Blood-derived Products Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Blood-derived Products Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Blood-derived Products Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Therapeutics Image Figure 28. Global Therapeutics Sales YoY Growth (2021-2032) & (t) Figure 29. Excipient Image Figure 30. Global Excipient Sales YoY Growth (2021-2032) & (t) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (t) Figure 33. Global Blood-derived Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Blood-derived Products Market Share by Application 2025 VS 2032 Figure 35. North America Blood-derived Products Sales Market Share in Volume by Application in 2025 Figure 36. North America Blood-derived Products Sales Market Share in Value by Application in 2025 Figure 37. Europe Blood-derived Products Sales Market Share in Volume by Application in 2025 Figure 38. Europe Blood-derived Products Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Blood-derived Products Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Blood-derived Products Sales Market Share in Value by Application in 2025 Figure 41. Latin America Blood-derived Products Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Blood-derived Products Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Blood-derived Products Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Blood-derived Products Sales Market Share in Value by Application in 2025 Figure 45. North America Blood-derived Products Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. North America Blood-derived Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Blood-derived Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Blood-derived Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Blood-derived Products Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Europe Blood-derived Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Blood-derived Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Blood-derived Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Blood-derived Products Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Asia-Pacific Blood-derived Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Blood-derived Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Blood-derived Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Blood-derived Products Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Latin America Blood-derived Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Blood-derived Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Blood-derived Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Blood-derived Products Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Middle East and Africa Blood-derived Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Blood-derived Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Blood-derived Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Blood-derived Products Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Blood-derived Products Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factors
  • Immunoglobulins
  • Albumin
  • Others
Applications
  • Therapeutics
  • Excipient
  • Other
Companies covered
  • Yuanda Shuyang
  • Takeda
  • Weiguang Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Shanghai RAAS
  • Hualan Bio
  • Boya Bio
  • CBPO
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood-derived Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Blood-derived Products Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Blood-derived Products Market by Type
  6. 1.3.1 Coagulation Factors
  7. 1.3.2 Immunoglobulins
  8. 1.3.3 Albumin
  9. 1.3.4 Others
  10. 1.4 Global Blood-derived Products Market Size by Type
  11. 1.4.1 Global Blood-derived Products Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Blood-derived Products Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Blood-derived Products Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Blood-derived Products Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Blood-derived Products Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Blood-derived Products Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Blood-derived Products Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Blood-derived Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Blood-derived Products Industry Trends
  2. 2.2 Blood-derived Products Industry Drivers
  3. 2.3 Blood-derived Products Industry Opportunities and Challenges
  4. 2.4 Blood-derived Products Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Blood-derived Products Revenue (2021-2026)
  2. 3.2 Global Top Players by Blood-derived Products Sales (2021-2026)
  3. 3.3 Global Top Players by Blood-derived Products Price (2021-2026)
  4. 3.4 Global Blood-derived Products Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood-derived Products Major Company Production Sites & Headquarters
  6. 3.6 Global Blood-derived Products Company, Product Type & Application
  7. 3.7 Global Blood-derived Products Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood-derived Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood-derived Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood-derived Products Tier 1, Tier 2, and Tier 3
4 Blood-derived Products Regional Status and Outlook
  1. 4.1 Global Blood-derived Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Blood-derived Products Historic Market Size by Region
  3. 4.2.1 Global Blood-derived Products Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Blood-derived Products Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Blood-derived Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Blood-derived Products Forecasted Market Size by Region
  7. 4.3.1 Global Blood-derived Products Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Blood-derived Products Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Blood-derived Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Blood-derived Products by Application
  1. 5.1 Blood-derived Products Market by Application
  2. 5.1.1 Therapeutics
  3. 5.1.2 Excipient
  4. 5.1.3 Other
  5. 5.2 Global Blood-derived Products Market Size by Application
  6. 5.2.1 Global Blood-derived Products Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Blood-derived Products Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Blood-derived Products Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Blood-derived Products Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Blood-derived Products Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Blood-derived Products Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Blood-derived Products Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Blood-derived Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yuanda Shuyang
  2. 6.1.1 Yuanda Shuyang Company Information
  3. 6.1.2 Yuanda Shuyang Business Overview
  4. 6.1.3 Yuanda Shuyang Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yuanda Shuyang Blood-derived Products Product Portfolio
  6. 6.1.5 Yuanda Shuyang Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Blood-derived Products Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Weiguang Bio
  14. 6.3.1 Weiguang Bio Company Information
  15. 6.3.2 Weiguang Bio Business Overview
  16. 6.3.3 Weiguang Bio Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Weiguang Bio Blood-derived Products Product Portfolio
  18. 6.3.5 Weiguang Bio Recent Developments
  19. 6.4 Tiantan Bio
  20. 6.4.1 Tiantan Bio Company Information
  21. 6.4.2 Tiantan Bio Business Overview
  22. 6.4.3 Tiantan Bio Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tiantan Bio Blood-derived Products Product Portfolio
  24. 6.4.5 Tiantan Bio Recent Developments
  25. 6.5 Shuanglin Bio
  26. 6.5.1 Shuanglin Bio Company Information
  27. 6.5.2 Shuanglin Bio Business Overview
  28. 6.5.3 Shuanglin Bio Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shuanglin Bio Blood-derived Products Product Portfolio
  30. 6.5.5 Shuanglin Bio Recent Developments
  31. 6.6 Shanghai RAAS
  32. 6.6.1 Shanghai RAAS Company Information
  33. 6.6.2 Shanghai RAAS Business Overview
  34. 6.6.3 Shanghai RAAS Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai RAAS Blood-derived Products Product Portfolio
  36. 6.6.5 Shanghai RAAS Recent Developments
  37. 6.7 Hualan Bio
  38. 6.7.1 Hualan Bio Company Information
  39. 6.7.2 Hualan Bio Business Overview
  40. 6.7.3 Hualan Bio Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hualan Bio Blood-derived Products Product Portfolio
  42. 6.7.5 Hualan Bio Recent Developments
  43. 6.8 Boya Bio
  44. 6.8.1 Boya Bio Company Information
  45. 6.8.2 Boya Bio Business Overview
  46. 6.8.3 Boya Bio Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Boya Bio Blood-derived Products Product Portfolio
  48. 6.8.5 Boya Bio Recent Developments
  49. 6.9 CBPO
  50. 6.9.1 CBPO Company Information
  51. 6.9.2 CBPO Business Overview
  52. 6.9.3 CBPO Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CBPO Blood-derived Products Product Portfolio
  54. 6.9.5 CBPO Recent Developments
  55. 6.10 Octapharma
  56. 6.10.1 Octapharma Company Information
  57. 6.10.2 Octapharma Business Overview
  58. 6.10.3 Octapharma Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Octapharma Blood-derived Products Product Portfolio
  60. 6.10.5 Octapharma Recent Developments
  61. 6.11 LFB Group
  62. 6.11.1 LFB Group Company Information
  63. 6.11.2 LFB Group Business Overview
  64. 6.11.3 LFB Group Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 LFB Group Blood-derived Products Product Portfolio
  66. 6.11.5 LFB Group Recent Developments
  67. 6.12 Kedrion
  68. 6.12.1 Kedrion Company Information
  69. 6.12.2 Kedrion Business Overview
  70. 6.12.3 Kedrion Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kedrion Blood-derived Products Product Portfolio
  72. 6.12.5 Kedrion Recent Developments
  73. 6.13 Grifols
  74. 6.13.1 Grifols Company Information
  75. 6.13.2 Grifols Business Overview
  76. 6.13.3 Grifols Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Grifols Blood-derived Products Product Portfolio
  78. 6.13.5 Grifols Recent Developments
  79. 6.14 CSL
  80. 6.14.1 CSL Company Information
  81. 6.14.2 CSL Business Overview
  82. 6.14.3 CSL Blood-derived Products Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 CSL Blood-derived Products Product Portfolio
  84. 6.14.5 CSL Recent Developments
7 North America by Country
  1. 7.1 North America Blood-derived Products Sales by Country
  2. 7.1.1 North America Blood-derived Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Blood-derived Products Sales by Country (2021-2026)
  4. 7.1.3 North America Blood-derived Products Sales Forecast by Country (2027-2032)
  5. 7.2 North America Blood-derived Products Market Size by Country
  6. 7.2.1 North America Blood-derived Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Blood-derived Products Market Size by Country (2021-2026)
  8. 7.2.3 North America Blood-derived Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Blood-derived Products Sales by Country
  2. 8.1.1 Europe Blood-derived Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Blood-derived Products Sales by Country (2021-2026)
  4. 8.1.3 Europe Blood-derived Products Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Blood-derived Products Market Size by Country
  6. 8.2.1 Europe Blood-derived Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Blood-derived Products Market Size by Country (2021-2026)
  8. 8.2.3 Europe Blood-derived Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Blood-derived Products Sales by Country
  2. 9.1.1 Asia-Pacific Blood-derived Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Blood-derived Products Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Blood-derived Products Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Blood-derived Products Market Size by Country
  6. 9.2.1 Asia-Pacific Blood-derived Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Blood-derived Products Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Blood-derived Products Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Blood-derived Products Sales by Country
  2. 10.1.1 South America Blood-derived Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Blood-derived Products Sales by Country (2021-2026)
  4. 10.1.3 South America Blood-derived Products Sales Forecast by Country (2027-2032)
  5. 10.2 South America Blood-derived Products Market Size by Country
  6. 10.2.1 South America Blood-derived Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Blood-derived Products Market Size by Country (2021-2026)
  8. 10.2.3 South America Blood-derived Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Blood-derived Products Sales by Country
  2. 11.1.1 Middle East and Africa Blood-derived Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Blood-derived Products Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Blood-derived Products Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Blood-derived Products Market Size by Country
  6. 11.2.1 Middle East and Africa Blood-derived Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Blood-derived Products Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Blood-derived Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Blood-derived Products Value Chain Analysis
  2. 12.1.1 Blood-derived Products Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Blood-derived Products Production Mode & Process
  7. 12.2 Blood-derived Products Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Blood-derived Products Distributors
  10. 12.2.3 Blood-derived Products Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst